Also, an in vivo study demonstrated that GDF2 suppressed endothelial cell proliferation in healthy control subjects but increased it in PAH patients with BMPR2 variants, which supported evidence of switching to the ActR-IIA/IIB rather than the BMPR2 downstream signaling pathway in PAH [36]. The gene discussed is GDF2; the disease is pulmonary arterial hypertension.